ACET

Adicet Bio
ACET

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$49.73M
EV
$-0.11B
Shares Outstanding
82.69M
Beta
1.64

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$6.40
P/E 2025E
-
P/Revenue 2025E
10.46x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Adicet Bio, Inc.

gainify
ACET

Adicet Bio, Inc.

ACET

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. The company offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable ...

Sector

Healthcare

Industry

Biotechnology

CEO

Schor, Chen

Employees

152

IPO Date

2018-01-26

Headquarters

131 Dartmouth Street, 3rd Floor, Boston, Massachusetts, 02116, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved